Discover the therapeutic benefits of the "parent" of cannabinoids

"$170 Million Market at Risk." Strict regulations could collapse the medicinal industry in the country, experts suggest

International and national experts gather in São Paulo to deepen discussions and research on the use for treatment in various specialties

The country is going through a crucial moment for the regulation of medicinal cannabis

The Master Chef host has also commented on his social media about the importance of cannabidiol for the treatment of his daughter diagnosed with a rare syndrome.

Public consultation is launched for preliminary version, but sector agents' criticisms question the scope and composition of the medication

Unveiling the myths and truths about how the cannabis compound works in the human body

State deputies present proposal to offer therapeutic treatment based on cannabidiol to patients in vulnerable situations

Historical use of medicinal cannabis is highlighted at the launch ceremony

According to the World Health Organization (WHO), CBD should not be considered an internationally controlled substance, as it does not have the potential for dependence or abuse.

The medicinal use of the plant advances and points to benefits in the treatment of pathologies in animals

The Federal Bill that authorizes and sets regulations for cultivation and other issues, PL399/2015, is still pending. Some municipalities have already implemented their initiatives on the subject since 2021. Now, with the law sanctioned in the state of São Paulo and

The Bill provides for the distribution of cannabis-based medicines through the SUS of the State of São Paulo

What to expect in the coming years regarding the cannabis agenda and what some lawmakers say about the development of the topic from now on

The growing recognition of cannabis for its therapeutic potential suggests that the plant can improve human brain health

Discover five important facts that will help you when investing your money in one of the fastest-growing sectors in Brazil and worldwide

The twelfth product approved by Anvisa, which will start being distributed at the end of May, is Zion Medpharma's Cannabis sativa Extract

“I never imagined we would get this far, but I knew we wouldn't stop growing,” Cassiano Gomes, executive director and founder of Abrace Esperança.

Tomorrow (03/08), at 7 PM, our Super Live Q&A will take place with our scientific director, Dr. Pedro Pierro, answering questions from doctors, patients, and those interested in the topic.

The bill was presented by Councilwoman Elzuila Calisto this October and will proceed to a vote.